1. Home
  2. SAGE vs DDL Comparison

SAGE vs DDL Comparison

Compare SAGE & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • DDL
  • Stock Information
  • Founded
  • SAGE 2010
  • DDL 2014
  • Country
  • SAGE United States
  • DDL China
  • Employees
  • SAGE N/A
  • DDL N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • DDL Catalog/Specialty Distribution
  • Sector
  • SAGE Health Care
  • DDL Consumer Discretionary
  • Exchange
  • SAGE Nasdaq
  • DDL Nasdaq
  • Market Cap
  • SAGE 413.9M
  • DDL 457.4M
  • IPO Year
  • SAGE 2014
  • DDL 2021
  • Fundamental
  • Price
  • SAGE $9.30
  • DDL $2.00
  • Analyst Decision
  • SAGE Hold
  • DDL
  • Analyst Count
  • SAGE 18
  • DDL 0
  • Target Price
  • SAGE $10.06
  • DDL N/A
  • AVG Volume (30 Days)
  • SAGE 2.4M
  • DDL 636.2K
  • Earning Date
  • SAGE 07-30-2025
  • DDL 08-06-2025
  • Dividend Yield
  • SAGE N/A
  • DDL N/A
  • EPS Growth
  • SAGE N/A
  • DDL N/A
  • EPS
  • SAGE N/A
  • DDL 0.18
  • Revenue
  • SAGE $47,404,000.00
  • DDL $3,241,404,122.00
  • Revenue This Year
  • SAGE $102.21
  • DDL $8.80
  • Revenue Next Year
  • SAGE $43.01
  • DDL $11.75
  • P/E Ratio
  • SAGE N/A
  • DDL $11.02
  • Revenue Growth
  • SAGE N/A
  • DDL 17.62
  • 52 Week Low
  • SAGE $4.62
  • DDL $1.62
  • 52 Week High
  • SAGE $13.47
  • DDL $4.79
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 78.92
  • DDL 39.48
  • Support Level
  • SAGE $6.44
  • DDL $2.01
  • Resistance Level
  • SAGE $9.33
  • DDL $2.29
  • Average True Range (ATR)
  • SAGE 0.26
  • DDL 0.08
  • MACD
  • SAGE 0.33
  • DDL 0.01
  • Stochastic Oscillator
  • SAGE 98.98
  • DDL 3.33

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

Share on Social Networks: